Omnicell, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Omnicell, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Debt Due Cover Ratio: Debt due within a year is covered 10.6 times by its yearly operating cash. Higher than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
3.0×Over the last 3 years its own operating cash covered its investment spending (capex) 3.0 times.
Higher than 79% of Healthcare companies in United States.
Cash Locked Ratio
$23For every $100 of sales, $23 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $29 tied up three years earlier.
Less money tied up than 52% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 9%
Sales fell 9% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-9% / -11%In 3 years sales changed by -9% while total assets changed by -11%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
10.6×Debt due within a year is covered 10.6 times by its yearly operating cash.
Higher than 85% of Healthcare companies in United States.
Cash Cushion Ratio
+0%Cash, after subtracting all debt, equals 0% of its market value (net cash).
Lower than 67% of Healthcare companies in United States.
Tangible Assets Ratio
51%Of every $100 the company owns, $51 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 78% of Healthcare companies in United States.
Tangible Net Worth Ratio
22%Of every $100 of net worth, $22 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 65% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Omnicell, Inc. owes $0.35 for every $1 it owns. Net profit fell 84% in the year to Dec 2025, and shrank 29% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
44.2Investors pay $44.2 for every $1 of Omnicell, Inc.'s yearly profit, higher than 76% of Healthcare companies in United States.
P/B ratio
1.31The share price is 1.31 times Omnicell, Inc.'s book value per share, lower than 72% of Healthcare companies in United States.
Market cap
$1.7 BThe total market value of all of Omnicell, Inc.'s shares at today's price (share price × number of shares), larger than 71% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.3 BWhat Omnicell, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$28.40Net worth divided by the number of shares. The share price of $37.10 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
3.1%Omnicell, Inc. earned 3.1% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.
Owes vs Owns
0.35×Omnicell, Inc. owes $0.35 for every $1 it owns (low), lower than 55% of Healthcare companies in United States.
Dividend yield
NoneOmnicell, Inc. does not currently pay a dividend.
Revenue growth
+7%Revenue rose 7% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Profit growth
-84%Net profit fell 84% in the year to Dec 2025, and shrank 29% a year on average over 3 years.
Profit margin
0.2%Omnicell, Inc. keeps $0 of every $100 of revenue as net profit.
Cash quality
62.0×Cash from Omnicell, Inc.'s business was 62.0× its reported profit in the year to Dec 2025 — its profit turned into cash.
Cash vs debt
Net cashOmnicell, Inc. held $7 M more cash than debt (net cash) at Dec 2025.
Questions
What is Omnicell, Inc.'s P/E ratio?
Investors pay $44.2 for every $1 of Omnicell, Inc.'s yearly profit, higher than 76% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Omnicell, Inc.: $1.7 B ÷ $1.3 B (30 Jun 2026) = 1.3.
What is Omnicell, Inc.'s return on equity?
Omnicell, Inc. earned 3.1% on its shareholders' money over the last year, higher than 78% of Healthcare companies in United States.
How much does Omnicell, Inc. owe compared with what it owns?
Omnicell, Inc. owes $0.35 for every $1 it owns (low), lower than 55% of Healthcare companies in United States.
Does Omnicell, Inc. pay a dividend?
No. Omnicell, Inc. does not currently pay a dividend.
Is Omnicell, Inc.'s revenue growing?
Revenue rose 7% in the year to Dec 2025, and shrank 3% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.